Ireland - English - HPRA (Health Products Regulatory Authority)

vetoquinol ireland limited - marbofloxacin - solution for injection - 100 milligram(s)/millilitre - marbofloxacin - cattle, pigs - antibacterial

Australia - English - Department of Health (Therapeutic Goods Administration)

aft pharmaceuticals pty ltd - levetiracetam, quantity: 10 % w/v - oral liquid, solution - excipient ingredients: acesulfame potassium; propyl hydroxybenzoate; purified water; maltitol solution; glycerol; sodium citrate dihydrate; methyl hydroxybenzoate; ammonium glycyrrhizinate; citric acid monohydrate; flavour - levetiracetam-aft oral solution is indicated for:,use in epileptic patients aged 4 years and older, initially as add on therapy, in the treatment of partial onset seizures with or without secondary generalisation,,monotherapy in the treatment of partial onset seizures, with or without secondary generalisation, in patients from 16 years of age with newly diagnosed epilepsy.,add on therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy (jme),and,add on therapy in the treatment of primary generalized tonic-clonic seizures in adults and children from 4 years of age with idiopathic generalized epilepsy (ige).,levetiracetam-aft concentrate solution for iv infusion after dilution is an alternative for patients when oral administration is temporarily not feasible.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

special order - glycerol - solution for injection - 1ml/1ml

New Zealand - English - Medsafe (Medicines Safety Authority)

novo nordisk pharmaceuticals ltd - insulin aspart 100 u/ml;   - solution for injection - 100 u/ml - active: insulin aspart 100 u/ml   excipient: dibasic sodium phosphate dihydrate glycerol hydrochloric acid metacresol phenol sodium chloride sodium hydroxide water for injection zinc as the chloride - the treatment of diabetes mellitus.

New Zealand - English - Medsafe (Medicines Safety Authority)

novo nordisk pharmaceuticals ltd - insulin aspart 100 u/ml;   - solution for injection - 100 u/ml - active: insulin aspart 100 u/ml   excipient: dibasic sodium phosphate dihydrate glycerol hydrochloric acid metacresol phenol sodium chloride sodium hydroxide water for injection zinc as the choloride - the treatment of diabetes mellitus.

New Zealand - English - Medsafe (Medicines Safety Authority)

novo nordisk pharmaceuticals ltd - insulin aspart 100 u/ml;   - solution for injection - 100 u/ml - active: insulin aspart 100 u/ml   excipient: dibasic sodium phosphate dihydrate glycerol hydrochloric acid metacresol phenol sodium chloride sodium hydroxide water for injection zinc - treatment of diabetes mellitus

New Zealand - English - Medsafe (Medicines Safety Authority)

novo nordisk pharmaceuticals ltd - insulin detemir 100 u/ml - solution for injection - 100 u/ml - active: insulin detemir 100 u/ml excipient: dibasic sodium phosphate dihydrate glycerol hydrochloric acid metacresol phenol sodium chloride sodium hydroxide water for injection zinc - for the treatment of diabetes mellitus

New Zealand - English - Medsafe (Medicines Safety Authority)

astrazeneca limited - goserelin acetate 11.34mg equivalent to 10.8 mg goserelin;   - injection (depot) - 10.8 mg - active: goserelin acetate 11.34mg equivalent to 10.8 mg goserelin   excipient: polyglactin - zoladex 10.8 mg is indicated for the management of: 1. prostate cancer suitable for hormonal manipulation.

Ireland - English - HPRA (Health Products Regulatory Authority)

merus labs luxco ii s.à.r.l. - glyceryl trinitrate - solution for infusion - 1 milligram(s)/millilitre - organic nitrates; glyceryl trinitrate

Ireland - English - HPRA (Health Products Regulatory Authority)

merus labs luxco ii s.à.r.l. - glyceryl trinitrate - solution for infusion - 1 milligram(s)/millilitre - organic nitrates; glyceryl trinitrate